ConductScience.org, home

Paper40655152

Virus-host interaction mechanisms in interferon therapy for hepatitis B virus infection: recent advances.

Zhang J and 5 others. Front Immunol, 2025. Cited by 4 papers, by iCite.

11 sourcespapers-2026-11-12-0.1.0

Download JSON
Cite this record

ConductScience Library. Virus-host interaction mechanisms in interferon therapy for hepatitis B virus infection: recent advances. Papers, record 40655152. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/40655152

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Virus-host interaction mechanisms in interferon therapy for hepatitis B virus infection: recent advances.
PubMed
Journal
Front Immunol
PubMed
Year
2025
PubMed
Publication types
Journal Article, Review
PubMed
Citations, by iCite
4
iCite
Revised in PubMed
2025-07-16
PubMed

Authors6

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Zhang JJiebing
2Lou TTao
3Zhu MMinmin
4Wang CChengkang
5Gong KKai
6Wu YYingping

Source PubMed

Download CSV of authors

Topics8

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Hepatitis B virusMajor topic
Antiviral AgentsMajor topic
Hepatitis B, ChronicMajor topic
Host-Pathogen InteractionsMajor topic
InterferonsMajor topic
Humans
Interferon-alpha
Animals

Source PubMed

Download CSV of topics

References163

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
117672864Cytidine deaminase APOBEC3B interacts with heterogeneous nuclear ribonucleoprotein K and suppresses hepatitis B virus expression.Cell Microbiol2008https://conductscience.org/library/papers/17672864PubMed
238975233Interferon-α could induce liver steatosis to promote HBsAg loss by increasing triglyceride level.Heliyon2024https://conductscience.org/library/papers/38975233PubMed
39300041Naturally occurring hepatitis B virus genomes bearing the hallmarks of retroviral G-->A hypermutation.Virology1997https://conductscience.org/library/papers/9300041PubMed
439854241Antiviral Mx proteins have an ancient origin and widespread distribution among eukaryotes.Proc Natl Acad Sci U S A2025https://conductscience.org/library/papers/39854241PubMed
531333675The Commensal Microbiota and Viral Infection: A Comprehensive Review.Front Immunol2019https://conductscience.org/library/papers/31333675PubMed
637475028Triple motif proteins 19 and 38 correlated with treatment responses and HBsAg clearance in HBeAg-negative chronic hepatitis B patients during peg-IFN-α therapy.Virol J2023https://conductscience.org/library/papers/37475028PubMed
734021034RNA helicase DDX5 enables STAT1 mRNA translation and interferon signalling in hepatitis B virus replicating hepatocytes.Gut2022https://conductscience.org/library/papers/34021034PubMed
830755454Interferon-induced guanylate-binding proteins: Guardians of host defense in health and disease.J Exp Med2019https://conductscience.org/library/papers/30755454PubMed
938905278Guanylate-Binding Protein 1 (GBP1) Enhances IFN-α Mediated Antiviral Activity against Hepatitis B Virus Infection.Pol J Microbiol2024https://conductscience.org/library/papers/38905278PubMed
1035080443Myxovirus Resistance Protein A as a Marker of Viral Cause of Illness in Children Hospitalized with an Acute Infection.Microbiol Spectr2022https://conductscience.org/library/papers/35080443PubMed
1133811250Bayesian analysis of cytokines and chemokine identifies immune pathways of HBsAg loss during chronic hepatitis B treatment.Sci Rep2021https://conductscience.org/library/papers/33811250PubMed
1238376650Functional cure is associated with younger age in children undergoing antiviral treatment for active chronic hepatitis B.Hepatol Int2024https://conductscience.org/library/papers/38376650PubMed
1319161414Inborn errors of interferon (IFN)-mediated immunity in humans: insights into the respective roles of IFN-alpha/beta, IFN-gamma, and IFN-lambda in host defense.Immunol Rev2008https://conductscience.org/library/papers/19161414PubMed
1437166302Mitochondrial Glycerol-3-Phosphate Dehydrogenase Restricts HBV Replication via the TRIM28-Mediated Degradation of HBx.J Virol2023https://conductscience.org/library/papers/37166302PubMed
1533424840Immunomodulation Induced During Interferon-α Therapy Impairs the Anti-HBV Immune Response Through CD24+CD38hi B Cells.Front Immunol2020https://conductscience.org/library/papers/33424840PubMed
1616699026Lipid-mediated introduction of hepatitis B virus capsids into nonsusceptible cells allows highly efficient replication and facilitates the study of early infection events.J Virol2006https://conductscience.org/library/papers/16699026PubMed
1725048716Immunological aspects of antiviral therapy of chronic hepatitis B virus and hepatitis C virus infections.Hepatology2015https://conductscience.org/library/papers/25048716PubMed
1835135717Microbiota regulation of viral infections through interferon signaling.Trends Microbiol2022https://conductscience.org/library/papers/35135717PubMed
1933868257The Functional and Antiviral Activity of Interferon Alpha-Inducible IFI6 Against Hepatitis B Virus Replication and Gene Expression.Front Immunol2021https://conductscience.org/library/papers/33868257PubMed
2033845868Potential capacity of interferon-α to eliminate covalently closed circular DNA (cccDNA) in hepatocytes infected with hepatitis B virus.Gut Pathog2021https://conductscience.org/library/papers/33845868PubMed

See all 163 referencesDownload CSV of references

Cited by4

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 4 citations.

PMIDTitleJournalYearIn PapersSource
42798495Preventive and Therapeutic Vaccination for COVID-19 Using NASVAC.Euroasian J Hepatogastroenterol2026https://conductscience.org/library/papers/42798495PubMed
42036232[A real-world study of clinical cure in children with HBeAg-positive chronic hepatitis B from the Guangxi region].Zhonghua Gan Zang Bing Za Zhi2026https://conductscience.org/library/papers/42036232PubMed
41929478Editorial: Host factors in hepatitis B virus: mechanistic insights and implications for interferon therapy.Front Immunol2026https://conductscience.org/library/papers/41929478PubMed
41629081[Comparison of antiviral efficacy of nucleos(t)ide analogue monotherapy and its combination with interferon-α in children 1-6 years-old with HBeAg-positive chronic hepatitis B].Zhonghua Gan Zang Bing Za Zhi2026https://conductscience.org/library/papers/41629081PubMed

Download CSV of cited by

Genes1

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn Genes
IFNA13439PubTator's text mininghttps://conductscience.org/library/genes/3439

Source NCBI Gene

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/40655152

GET https://conductscience.org/api/papers/v1/40655152/references?page=2